Kenvue, Inc. (KVUE) has disclosed a new risk, in the Corporate Activity and Growth category. Kenvue, Inc. faces potential ...

Non-GAAP earnings per share of $0.29 in Q2 FY2025 beat expectations, but GAAP revenue missed estimates and GAAP net sales declined 4.0% from the prior year. Management lowered its FY2025 outlook, now ...

Malta-based food company Foster Clark Products (FCP) has acquired a 100% stake in Italian chips and savoury snacks producer ...

Kenvue cut its annual sales forecast on Thursday, as the consumer health company undergoes a strategic review aiming to boost ...

Wall Street analysts view the Band-Aid maker as an acquisition target after it came under pressure from investors, who have criticized the lackluster performance in its skin health and beauty segment ...

The Summit, N.J., drugmaker said Monday that both net and organic sales are likely to be down by low single-digit percentages from last year. It previously guided for net sales to grow 1% to 3%, and ...

(NYSE: KVUE) today announced financial results for the second quarter ended June 29, 2025. "Kenvue has a strong portfolio of ...

(Reuters) -Kenvue reported a second-quarter profit largely in line with Wall Street estimates on Thursday, amid a strategic ...

EARNINGS: The Johnson & Johnson spinoff, which makes Tylenol and Benadryl, is expected to post a profit of $482.3 million, or 25 cents a share, according to analysts surveyed by FactSet. That compares ...